港股异动︱丘钛科技涨近4%7月摄像头模组销量同比增长48.2%
格隆汇8月8日丨丘钛科技(1478.HK)现报6.88港元,涨3.93%,暂成交789万港元,最新总市值78.6亿港元。丘钛科技昨晚公布7月主营产品销量称,期内800万像素及以下摄像头模组同比增长39.4%至1666.7万件,环比增加3.3%;1000万像素及以上摄像头模组同比增长57.7%至1751.3万件,环比增长9.1%;摄像头模组销量合计3418万件,同比增长48.2%,环比增加6.2%;指纹识别模组销量同比减少17.3%至789万件,环比增加31%。摄像头模组产品销量同比增加主要由于公司摄像头模组市场的占有率上升;而指纹识别模组销量同比减少主要由于公司减少了电容式指纹识别模组的业务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.